NOTE vs. ABSI, CIGL, SY, PHLT, LTBR, IMXI, SHAP, PMTS, TRVG, and EGHT
Should you be buying FiscalNote stock or one of its competitors? The main competitors of FiscalNote include Absci (ABSI), Concorde International Group (CIGL), So-Young International (SY), Performant Healthcare (PHLT), Lightbridge (LTBR), International Money Express (IMXI), Spree Acquisition Corp. 1 (SHAP), CPI Card Group (PMTS), Trivago N.V. ADS (TRVG), and 8X8 (EGHT). These companies are all part of the "business services" industry.
FiscalNote vs. Its Competitors
FiscalNote (NYSE:NOTE) and Absci (NASDAQ:ABSI) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.
54.3% of FiscalNote shares are held by institutional investors. Comparatively, 52.1% of Absci shares are held by institutional investors. 40.2% of FiscalNote shares are held by insiders. Comparatively, 10.5% of Absci shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
In the previous week, FiscalNote had 4 more articles in the media than Absci. MarketBeat recorded 7 mentions for FiscalNote and 3 mentions for Absci. Absci's average media sentiment score of 0.37 beat FiscalNote's score of 0.10 indicating that Absci is being referred to more favorably in the news media.
FiscalNote has higher revenue and earnings than Absci. Absci is trading at a lower price-to-earnings ratio than FiscalNote, indicating that it is currently the more affordable of the two stocks.
FiscalNote has a net margin of -39.19% compared to Absci's net margin of -2,232.13%. Absci's return on equity of -53.69% beat FiscalNote's return on equity.
FiscalNote has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, Absci has a beta of 2.01, indicating that its share price is 101% more volatile than the S&P 500.
FiscalNote presently has a consensus price target of $2.63, indicating a potential upside of 251.11%. Absci has a consensus price target of $8.40, indicating a potential upside of 204.90%. Given FiscalNote's higher probable upside, research analysts plainly believe FiscalNote is more favorable than Absci.
Summary
FiscalNote beats Absci on 11 of the 15 factors compared between the two stocks.
Get FiscalNote News Delivered to You Automatically
Sign up to receive the latest news and ratings for NOTE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding NOTE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
FiscalNote Competitors List
Related Companies and Tools
This page (NYSE:NOTE) was last updated on 7/3/2025 by MarketBeat.com Staff